Abstract:In the conventional analysis of complex diseases, the control and case samples are assumed to be of great purity. However, due to the heterogeneity of disease samples, many disease genes are even not always consistently up-/down-regulated, leading to be under-estimated. This problem will seriously influence effective personalized diagnosis or treatment. The expression variance and expression covariance can address such a problem in a network manner. But, these analyses always require multiple samples rather than one sample, which is generally not available in clinical practice for each individual. To extract the common and specific network characteristics for individual patients in this paper, a novel differential network model, e.g. personalized dysfunctional gene network, is proposed to integrate those genes with different features, such as genes with the differential gene expression (DEG), genes with the differential expression variance (DEVG) and gene-pairs with the differential expression covariance (DECG) simultaneously, to construct personalized dysfunctional networks. This model uses a new statistic-like measurement on differential information, i.e., a differential score (DEVC), to reconstruct the differential expression network between groups of normal and diseased samples; and further quantitatively evaluate different feature genes in the patient-specific network for each individual. This DEVC-based differential expression network (DEVC-net) has been applied to the study of complex diseases for prostate cancer and diabetes. (1) Characterizing the global expression change between normal and diseased samples, the differential gene networks of those diseases were found to have a new bi-coloured topological structure, where their non hub-centred sub-networks are mainly composed of genes/proteins controlling various biological processes. (2) The differential expression variance/covariance rather than differential expression is new informative sources, and can be used to identify genes or gene-pairs with discriminative power, which are ignored by traditional methods. (3) More importantly, DEVC-net is effective to measure the expression state or activity of different feature genes and their network or modules in one sample for an individual. All of these results support that DEVC-net indeed has a clear advantage to effectively extract discriminatively interpretable features of gene/protein network of one sample (i.e. personalized dysfunctional network) even when disease samples are heterogeneous, and thus can provide new features like gene-pairs, in addition to the conventional individual genes, to the analysis of the personalized diagnosis and prognosis, and a better understanding on the underlying biological mechanisms.

A Powerful Score-Based Statistical Test for Group Difference in Weighted Biological Networks.

A Powerful Weighted Statistic for Detecting Group Differences of Directed Biological Networks

PMINR: Pointwise Mutual Information-Based Network Regression – with Application to Studies of Lung Cancer and Alzheimer’s Disease

Incorporating prior biological knowledge for network-based differential gene expression analysis using differentially weighted graphical LASSO

A Novel Chi-Square Statistic for Detecting Group Differences Between Pathways in Systems Epidemiology

Discovering Disease-Associated Genes in Weighted Protein–protein Interaction Networks

A Differential Degree Test for Comparing Brain Networks

Comparative network stratification analysis for identifying functional interpretable network biomarkers

Covariate-Adjusted Inference for Differential Analysis of High-Dimensional Networks

Identifying Disease Genes from Ppi Networks Weighted by Gene Expression under Different Conditions

Weighted Graph-Based Two-Sample Test via Empirical Likelihood

Unravelling Personalized Dysfunctional Gene Network of Complex Diseases Based on Differential Network Model.

Identifying the critical states of complex diseases by the dynamic change of multivariate distribution

Identification of Human Disease Genes from Interactome Network Using Graphlet Interaction.

A Computational Method Based On The Integration Of Heterogeneous Networks For Predicting Disease-Gene Associations

Weighted minimum feedback vertex sets and implementation in human cancer genes detection

A Statistical Physics Approach for Disease Module Detection

Network propagation for GWAS analysis: a practical guide to leveraging molecular networks for disease gene discovery

A Computational Method of Defining Potential Biomarkers based on Differential Sub-Networks

Inferring Differential Networks by Integrating Gene Expression Data With Additional Knowledge

Identifying the Critical States and Dynamic Network Biomarkers of Cancers Based on Network Entropy